202 related articles for article (PubMed ID: 33257571)
1. Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane association.
Zhou M; Kuruvilla L; Shi X; Viviano S; Ahearn IM; Amendola CR; Su W; Badri S; Mahaffey J; Fehrenbacher N; Skok J; Schlessinger J; Turk BE; Calderwood DA; Philips MR
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31914-31922. PubMed ID: 33257571
[TBL] [Abstract][Full Text] [Related]
2. Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox AD; Der CJ; Philips MR
Clin Cancer Res; 2015 Apr; 21(8):1819-27. PubMed ID: 25878363
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
4. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
5. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody raised against human EZH2 cross-reacts with the RNA-binding protein SAFB.
Cherney RE; Mills CA; Herring LE; Braceros AK; Calabrese JM
Biol Open; 2023 Jun; 12(6):. PubMed ID: 37283223
[TBL] [Abstract][Full Text] [Related]
7. The increasing diversity of functions attributed to the SAFB family of RNA-/DNA-binding proteins.
Norman M; Rivers C; Lee YB; Idris J; Uney J
Biochem J; 2016 Dec; 473(23):4271-4288. PubMed ID: 27888239
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.
Drakouli S; Lyberopoulou A; Papathanassiou M; Mylonis I; Georgatsou E
FEBS J; 2017 Aug; 284(15):2482-2500. PubMed ID: 28627136
[TBL] [Abstract][Full Text] [Related]
9. Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer.
Liu M; Sjogren AK; Karlsson C; Ibrahim MX; Andersson KM; Olofsson FJ; Wahlstrom AM; Dalin M; Yu H; Chen Z; Yang SH; Young SG; Bergo MO
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6471-6. PubMed ID: 20308544
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HSF1 and SAFB Granule Formation Enhances Apoptosis Induced by Heat Stress.
Watanabe K; Ohtsuki T
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067147
[TBL] [Abstract][Full Text] [Related]
11. Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.
Kazi A; Xiang S; Yang H; Chen L; Kennedy P; Ayaz M; Fletcher S; Cummings C; Lawrence HR; Beato F; Kang Y; Kim MP; Delitto A; Underwood PW; Fleming JB; Trevino JG; Hamilton AD; Sebti SM
Clin Cancer Res; 2019 Oct; 25(19):5984-5996. PubMed ID: 31227505
[TBL] [Abstract][Full Text] [Related]
12. SAFB re-distribution marks steps of the apoptotic process.
Lee YB; Colley S; Norman M; Biamonti G; Uney JB
Exp Cell Res; 2007 Nov; 313(18):3914-23. PubMed ID: 17643427
[TBL] [Abstract][Full Text] [Related]
13. The Nuclear Matrix Protein SAFB Cooperates with Major Satellite RNAs to Stabilize Heterochromatin Architecture Partially through Phase Separation.
Huo X; Ji L; Zhang Y; Lv P; Cao X; Wang Q; Yan Z; Dong S; Du D; Zhang F; Wei G; Liu Y; Wen B
Mol Cell; 2020 Jan; 77(2):368-383.e7. PubMed ID: 31677973
[TBL] [Abstract][Full Text] [Related]
14. The G protein-coupled receptor GPR31 promotes membrane association of KRAS.
Fehrenbacher N; Tojal da Silva I; Ramirez C; Zhou Y; Cho KJ; Kuchay S; Shi J; Thomas S; Pagano M; Hancock JF; Bar-Sagi D; Philips MR
J Cell Biol; 2017 Aug; 216(8):2329-2338. PubMed ID: 28619714
[TBL] [Abstract][Full Text] [Related]
15. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
16. Restricted substrate specificity for the geranylgeranyltransferase-I enzyme in Cryptococcus neoformans: implications for virulence.
Selvig K; Ballou ER; Nichols CB; Alspaugh JA
Eukaryot Cell; 2013 Nov; 12(11):1462-71. PubMed ID: 24014765
[TBL] [Abstract][Full Text] [Related]
17. Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERĪ±.
Hashimoto T; Matsuda K; Kawata M
J Cell Biochem; 2012 Sep; 113(9):3039-50. PubMed ID: 22566185
[TBL] [Abstract][Full Text] [Related]
18. Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?
Oesterreich S
J Cell Biochem; 2003 Nov; 90(4):653-61. PubMed ID: 14587024
[TBL] [Abstract][Full Text] [Related]
19. Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2.
Sergeant KA; Bourgeois CF; Dalgliesh C; Venables JP; Stevenin J; Elliott DJ
J Cell Sci; 2007 Jan; 120(Pt 2):309-19. PubMed ID: 17200140
[TBL] [Abstract][Full Text] [Related]
20. Ras farnesyltransferase: a new therapeutic target.
Leonard DM
J Med Chem; 1997 Sep; 40(19):2971-90. PubMed ID: 9301658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
